These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 18939732)

  • 1. Perception and practice of sublingual immunotherapy among practicing allergists.
    Tucker MH; Tankersley MS;
    Ann Allergy Asthma Immunol; 2008 Oct; 101(4):419-25. PubMed ID: 18939732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perception and practice of sublingual immunotherapy among practicing allergists in the United States: a follow-up survey.
    Sikora JM; Tankersley MS;
    Ann Allergy Asthma Immunol; 2013 Mar; 110(3):194-197.e4. PubMed ID: 23548531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perception and practice of sublingual immunotherapy among practicing allergists in the United States: A follow-up survey.
    Sivam A; Tankersley M;
    Ann Allergy Asthma Immunol; 2019 Jun; 122(6):623-629.e2. PubMed ID: 30946915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survey on immunotherapy practice patterns: dose, dose adjustments, and duration.
    Larenas-Linnemann DE; Gupta P; Mithani S; Ponda P
    Ann Allergy Asthma Immunol; 2012 May; 108(5):373-378.e3. PubMed ID: 22541411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose adjustment practices among allergists for local reactions to immunotherapy.
    Coop CA; Tankersley MS
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):77-81. PubMed ID: 17650834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen immunotherapy practice patterns: a worldwide survey.
    Ponda P; Mithani S; Kopyltsova Y; Sison C; Gupta P; Larenas D; Bonagura VR
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):454-459.e7. PubMed ID: 22626600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual immunotherapy: a comprehensive review.
    Cox LS; Larenas Linnemann D; Nolte H; Weldon D; Finegold I; Nelson HS
    J Allergy Clin Immunol; 2006 May; 117(5):1021-35. PubMed ID: 16675328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of allergen immunotherapy practice patterns in the United States and Europe.
    Cox L; Jacobsen L
    Ann Allergy Asthma Immunol; 2009 Dec; 103(6):451-59; quiz 459-61, 495. PubMed ID: 20084837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.
    Pokladnikova J; Krcmova I; Vlcek J
    Ann Allergy Asthma Immunol; 2008 May; 100(5):482-9. PubMed ID: 18517082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific immunotherapy in children.
    Bufe A; Roberts G
    Clin Exp Allergy; 2011 Sep; 41(9):1256-62. PubMed ID: 21518041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The history of sublingual immunotherapy.
    Pajno GB; Barberi S
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
    Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
    Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of standardized extracts in allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):41-5. PubMed ID: 10887303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results.
    Esch RE; Bush RK; Peden D; Lockey RF
    Ann Allergy Asthma Immunol; 2008 May; 100(5):475-81. PubMed ID: 18517081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age and indications to SLIT.
    Terracciano L; Calcinai E; Avitabile S; Galli E
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):5-8. PubMed ID: 19944002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of patients for sublingual immunotherapy (SLIT) versus subcutaneous immunotherapy (SCIT).
    Tabatabaian F; Casale TB
    Allergy Asthma Proc; 2015; 36(2):100-4. PubMed ID: 25715238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sublingual immunotherapy in patients sensitised to Ambrosia. An open controlled study.
    Valle C; Bazzi S; Berra D; Sillano V; Puccinelli P; Parmiani S
    Allergol Immunopathol (Madr); 2000; 28(6):311-7. PubMed ID: 11269898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublingual immunotherapy.
    Esch RE
    Curr Opin Otolaryngol Head Neck Surg; 2008 Jun; 16(3):260-4. PubMed ID: 18475082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe.
    Nelson HS; Makatsori M; Calderon MA
    Immunol Allergy Clin North Am; 2016 Feb; 36(1):13-24. PubMed ID: 26617224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.